NIH to Fund Genome Grants

WASHlNGTON—The National Institutes of Health has invited investigators to apply for grants in two key areas related to the mapping and sequencing of the human genome. The announcement is the latest step in the federal government's expanding efforts to mobilize the research community for this billion-dollar project. The announcement, which appeared in the May 29 issue of the NIH Guide for Grants and Contracts (Vol. 16. no. 18), represents a continuation of policies outlined at a meeting las

Written bySusan Walton
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The announcement, which appeared in the May 29 issue of the NIH Guide for Grants and Contracts (Vol. 16. no. 18), represents a continuation of policies outlined at a meeting last October of the Advisory Committee to the Director of NIH. Participants at that meeting agreed that NIH should not abandon its current system of peer-reviewed grants to individual investigators in favor of a major initiative on the topic. The program announcement is an indication that NIH still holds to that policy.

Speculation that NIH might become more aggressive arose after an April 27 report to the Department of Energy from its Health and Environmental Research Advisory Committee. That group, chaired by Mortimer Mendelsohn of Lawrence Livermore National Laboratory, recommended that the Energy Department direct a mapping and sequencing project that will cost an estimated $200 million annually by 1993. The department is in the best position to lead such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies